原发性胆汁性胆管炎临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 原发性胆汁性胆管炎（国际通用名 primary biliary cholangitis）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖PBC、原发性胆汁性肝硬化等说法。
正在招募的原发性胆汁性胆管炎新药试验
Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy
III 期招募中美国NCT07424677Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
不适用招募中美国NCT04685200An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
不适用招募中DenmarkNCT05335603Biobank for Cholestatic Liver Diseases.
不适用招募中美国NCT03445585Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)
不适用招募中西班牙NCT07205874Swiss Primary Biliary Cholangitis Cohort Study
不适用招募中SwitzerlandNCT03146910A Study of SIPLIZUMAB in AILD and LT Patients
I 期招募中美国NCT06455280Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy
III 期招募中法国NCT06443606A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
III 期招募中美国NCT07387549Detection Program for Patients With Primary Biliary Cholangitis Lost in the System
不适用招募中西班牙NCT05919433Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
III 期招募中中国NCT06755541LEOPARD Prospective Validation Cohort 1
不适用招募中Belgium法国德国意大利NCT06723275
原发性胆汁性胆管炎试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。